A Randomized Control study To Assess The Efficacy Of topical keratolytics versus keratolytics delivered through iontophoresis in the treatment of wart over soles at a tertiary care centre
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/01/049095
- Lead Sponsor
- Menagadevi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ï?¬plantar verrucae for 1months or greater
ï?¬They should not have received any treatment for the wart(s) within 4 weeks of participation in the study
Patients more than 12 years and less than 60 years of age of both genders.
Willingness to take part in the study.
Exclusion Criteria
Uncontrolled diabetes
HIV infection.
History of taking immunocompromise medications.
circulatory or sensory disorders,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method decrease in number and size of wartTimepoint: At baseline,4weeks,8 weeks,12 weeks
- Secondary Outcome Measures
Name Time Method safety profileTimepoint: 12 weeks